AAA
ABBV icon

Adams Asset Advisors’s AbbVie ABBV Stock Holding History

Adams Asset Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$16.3M Sell
62,331
-581
-0.9% -$149K 1.66% 17
2026
Q2 		$15.8M Hold
62,912
– – 1.8% 19
2026
Q1 		$13.7M Hold
62,912
– – 1.53% 22
2025
Q4 		$14.4M Sell
62,912
-517
-0.8% -$118K 1.89% 13
2025
Q3 		$14.7M Hold
63,429
– – 1.89% 11
2025
Q2 		$11.8M Sell
63,429
-7,126
-10% -$1.32M 1.66% 16
2025
Q1 		$14.8M Hold
70,555
– – 2.03% 10
2024
Q4 		$12.5M Sell
70,555
-1,000
-1% -$184K 1.61% 14
2024
Q3 		$14.1M Sell
71,555
-254
-0.4% -$47.4K 1.87% 9
2024
Q2 		$12.3M Hold
71,809
– – 1.61% 14
2024
Q1 		$13.1M Sell
71,809
-362
-0.5% -$62.4K 1.69% 11
2023
Q4 		$11.2M Buy
72,171
+1,229
+2% +$179K 1.5% 14
2023
Q3 		$10.6M Buy
70,942
+6,080
+9% +$893K 1.42% 16
2023
Q2 		$8.74M Sell
64,862
-10,008
-13% -$1.47M 1.28% 18
2023
Q1 		$11.9M Hold
74,870
– – 1.6% 8
2022
Q4 		$12.1M Sell
74,870
-126
-0.2% -$19.3K 1.62% 9
2022
Q3 		$10.1M Buy
74,996
+280
+0.4% +$40.2K 1.56% 11
2022
Q2 		$11.4M Buy
74,716
+5,700
+8% +$871K 1.73% 10
2022
Q1 		$11.2M Sell
69,016
-4,873
-7% -$708K 1.64% 10
2021
Q4 		$10M Sell
73,889
-317
-0.4% -$37.4K 1.82% 9
2021
Q3 		$8M Buy
74,206
+5,009
+7% +$572K 1.61% 20
2021
Q2 		$7.79M Buy
69,197
+6,205
+10% +$699K 1.53% 27
2021
Q1 		$6.82M Sell
62,992
-13,177
-17% -$1.41M 1.47% 25
2020
Q4 		$8.16M Sell
76,169
-7,168
-9% -$689K 2.23% 9
2020
Q3 		$7.3M Hold
83,337
– – 2.32% 9
2020
Q2 		$8.18M Hold
83,337
– – 2.42% 5
2020
Q1 		$6.35M Buy
83,337
+1,540
+2% +$131K 2.54% 6
2019
Q4 		$7.24M Buy
81,797
+4,835
+6% +$401K 1.26% 13
2019
Q3 		$5.83M Buy
76,962
+3,987
+5% +$273K 0.95% 23
2019
Q2 		$5.31M Buy
72,975
+3,227
+5% +$254K 0.82% 30
2019
Q1 		$5.62M Buy
69,748
+959
+1% +$78.5K 0.75% 25
2018
Q4 		$6.34M Buy
68,789
+6,924
+11% +$609K 0.89% 16
2018
Q3 		$5.85M Buy
+61,865
New +$5.87M 0.63% 32

Other funds holding ABBV

HCM
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Adams Asset Advisors's ABBV Position: Q3 2026 in Review

Adams Asset Advisors reduced its AbbVie (ABBV) stake by 0.92% in Q3 2026, selling an estimated $149K and leaving 62,331 shares worth $16.3M. The position accounts for 1.66% of the portfolio, ranked #17.

Adams Asset Advisors first reported a position in ABBV in Q3 2018 and has held it in 33 quarters since. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Adams Asset Advisors held 62,331 shares of AbbVie worth $16.3M as of Q3 2026.
  • Adams Asset Advisors sold 581 AbbVie shares in Q3 2026, an estimated $149K.
  • AbbVie made up 1.66% of Adams Asset Advisors's portfolio in Q3 2026, its #17 holding.
  • Adams Asset Advisors first reported a position in AbbVie in Q3 2018 and has held it in 33 quarters since.
  • 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Adams Asset Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.